Delivery Order SPE2DB25D3306-SPE2DB26FUANU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,835.24 to AmerisourceBergen Drug Corp for Yuvafem 10 MCG vaginal inserts (18 count) on October 17, 2025, with completion scheduled for October 20, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,543.33 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count) on September 25, 2025, with a completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,752.65 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under a larger procurement vehicle. No set-aside designation was used for this...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.59 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 27, 2025, with completion scheduled for August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office based in Conshohocken, Pennsylvania. The delivery location is also Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18 count) with a contract ceiling value of $2,328.28. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $2,057.01 to AmerisourceBergen Drug Corp on August 15, 2025, for Yuvafem 10 micrograms vaginal insert (18 units). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction within the federal pharmaceutical supply chain. The contract is set to complete by August 18, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,607.76 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, classified as a non-set-aside award, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.09 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUANUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,061.54 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 units) on October 29, 2025, with completion expected by October 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement action supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates consistent capability to meet defense medical procurement requirements through competitive awards involving firm fixed-price delivery orders across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/29/25 |